Legato Capital Management LLC
Position in TVTX — Travere Therapeutics, Inc.
CIK 1442641
San Francisco, CA
Position in TVTX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$4,989,792
+$3,085,084 QoQ
Shares Held
87,833
+37.0% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Common Shares in TVTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legato Capital Management LLC holds $78,908,724 across 38 Biotechnology names. TVTX ranks #3 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
58,512 | $6,849,999 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
33,042 | $6,188,105 | |
| 3 | TVTX |
Travere Therapeutics, Inc.
This page
|
87,833 | $4,989,792 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
15,569 | $4,921,205 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
18,644 | $4,563,491 | |
| 6 | PVLA |
Palvella Therapeutics, Inc.
|
23,490 | $3,589,741 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
41,186 | $3,581,122 | |
| 8 | ELVN |
Enliven Therapeutics, Inc.
|
64,769 | $3,287,026 |
All Filings in TVTX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,989,792 | 87,833 | Shares | Other | 2026-08-06 | |
| 2026-03-31 | $1,904,708 | 64,110 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $3,344,750 | 87,536 | Shares | Other | 2026-02-06 | |
| 2025-09-30 | $1,697,617 | 71,030 | Shares | Other | 2025-11-12 | |
| 2025-03-31 | $586,539 | 32,731 | Shares | Other | 2025-05-06 | |
| No filing history on record for this holder in this stock. | ||||||